Clinical Trials Browser

Lung Neoplasms × Vorinostat × Clear all

NCT02638090 2025-12-22

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Active not recruiting

120 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00838929 2025-05-04

Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases

Phase 1 Completed

17 enrolled 8 charts

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

NCT00128102 2020-10-26

MK-0683-014

Phase 3 Completed

661 enrolled 18 charts

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT01059552 2019-11-27

NSCLC

Phase 1 Completed

Lung Neoplasms

NCT00702962 2018-10-22

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer

Phase 1/2 Terminated

8 enrolled 8 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00735826 2018-10-12

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer

Phase NA Completed

10 enrolled 7 charts

GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms

NCT00946673 2017-10-06

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Phase 1 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis